Literature DB >> 1437939

Worsening neurological status in late pregnancy: consider meningioma.

G V Narayansingh, S Ramsewak, J N Cross, R U Adam, W Kissoon.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1437939      PMCID： PMC2399342          DOI： 10.1136/pgmj.68.800.486

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Tumours of the central nervous system. Analysis of 476 cases observed at the University Hospital of the West Indies.

Authors:  G Char; J N Cross; V Persaud
Journal:  West Indian Med J       Date:  1987-09       Impact factor: 0.171

2.  A large meningioma presenting as a neurologic emergency in late pregnancy.

Authors:  R M DeGrood; W H Beemer; D E Fenner; A A Compton
Journal:  Obstet Gynecol       Date:  1987-03       Impact factor: 7.661

Review 3.  Neurosurgical, obstetric and endocrine aspects of meningioma during pregnancy.

Authors:  M Goldberg; Z H Rappaport
Journal:  Isr J Med Sci       Date:  1987-07

Review 4.  Pregnancy-related primary brain and spinal tumors.

Authors:  N C Roelvink; W Kamphorst; H A van Alphen; B R Rao
Journal:  Arch Neurol       Date:  1987-02
  4 in total
  3 in total

1.  Frontal lobe meningioma mimicking preeclampsia: A case study.

Authors:  Jinny Y Foo; Gregory K Davis; Mark A Brown
Journal:  Obstet Med       Date:  2017-05-15

Review 2.  Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis.

Authors:  Yosef Laviv; Victoria Ohla; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2016-06-16       Impact factor: 3.042

Review 3.  Management strategies and clinical follow-up of pregnant women with intracranial meningioma.

Authors:  Andreea Elena Dumitru; Anca Panaitescu; George Iancu; Francesca Gabriela Paslaru; Alexandru Catalin Paslaru; Radu Mircea Gorgan; Gheorghe Peltecu
Journal:  J Med Life       Date:  2021 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.